14 November 2013 in PLOS ONE
MPMaria Isabel Moraes Pinto
Maria Isabel Moraes Pinto
LCLilia Maria Carneiro Câmara
Lilia Maria Carneiro Câmara
Leprosy is a chronic disease, caused by Mycobacterium leprae, which poses a serious public health problem worldwide. Its high incidence in people under 15 years old in Ceará state, Brazil, reflects the difficulty of its control. The spectrum of clinical manifestations is associated with the immune response developed, with the Th1 and Th2 responses being related to the paucibacillary and multibacillary forms, respectively. Regulatory T cells (Treg), which can suppress Th1 and Th2 response, have received special attention in the literature and have been associated with development of chronic infections. However, their role in leprosy in individuals under 15 years old has not yet been elucidated. We evaluated the frequency of CD4+/CD8+CD25highFOXP3+ and CD4+/CD8+CD25highFOXP3high cells in leprosy patients and household contacts, in both cases under 15 years old. PBMC from 12 patients and 17 contacts were cultured for 72 hours with anti-CD3 and anti-CD28 (activators) or with activators associated with total sonicated fraction of M. leprae. After culture, the frequency of CD4+/CD8+ Treg was identified by flow cytometry. Cells stimulated by activators and antigen from multibacillary patients showed Treg frequencies almost two times that of the contacts: CD4+FOXP3+ (21.93±8.43 vs. 13.79±8.19%, p = 0.0500), CD4+FOXP3high (10.33±5.69 vs. 5.57±4.03%, p = 0.0362), CD8+FOXP3+ (13.88±9.19 vs. 6.18±5.56%, p = 0.0230) and CD8+FOXP3high (5.36±4.17 vs. 2.23±2.68%, p = 0.0461). Furthermore, the mean fluorescence intensity of FOXP3 in Treg was higher in multibacillary patients than in the contacts. Interestingly, there was a positive correlation of the bacillary index and number of lesions with the frequency of all Treg evaluated in patients. We have demonstrated for the first time that multibacillary leprosy patients under 15 years old have greater CD4+ and CD8+ Treg frequencies and these correlate with clinical and laboratorial aspects of disease. These findings suggest the involvement of these cells in the perpetuation of M. leprae infection.
1 January 2022 in Brazilian Journal of Medical and Biological Research
Clinical oncology has shown outstanding progress improving patient survival due to the incorporation of new drugs. However, treatment success may be reduced by the emergency of dose-limiting side effects, such as intestinal mucositis and diarrhea. Mucositis and diarrhea management is symptomatic, and there is no preventive therapy. Bacterial and fungal-based compounds have been suggested as an alternative for preventing the development of diarrhea in cancer patients. Using probiotics is safe and effective in immunocompetent individuals, but concerns remain during immunosuppressive conditions. Paraprobiotics, formulations composed of non-viable microorganisms, have been proposed to overcome such limitation. The present literature review discusses current evidence regarding the possible use of paraprobiotics as an alternative to probiotics to prevent gastrointestinal toxicity of cancer chemotherapy.
27 January 2023 in Revista de Atenção à Saúde
INTRODUÇÃO: A síndrome respiratória aguda grave-coronavírus 2 (SARS-CoV-2), apresenta heterogeneidade clínica, a depender das singularidades dos indivíduos. As doenças reumatológicas, que cursam com alterações imunológicas, além de, necessitarem da terapia imunomodulatória para seu controle, acabam por influenciar na responsividade à infecção pelo SARS-CoV-2. Contudo, tal associação, bem como os fatores de risco e de gravidade, não estão claramente elucidados. OBJETIVO: analisar os fatores associados à infecção e à hospitalização de pacientes reumatológicos pelo SARS-Cov-2. MATERIAIS E MÉTODOS: Trata-se de uma revisão de literatura narrativa, que utilizou as bases de dados PUBMED, Science Direct e o Portal Regional da Biblioteca Virtual de Saúde (BVS), com os descritores “Covid-19”, “Rheumatic Disease” and "Immunosuppression". Foram selecionadas 11 produções científicas para compor esta revisão. RESULTADOS: Doença reumatológica não foi associada à maior suscetibilidade à infecção/hospitalização por SARS-Cov-2. Em relação aos fatores demográficos, a associação com o aumento do risco de adoecimento/internação por Covid-19 não foi convergente. As comorbidades foram apontadas como fator de maior propensão para a infecção viral, já quanto às drogas antirreumáticas, houveram divergências. CONCLUSÕES: Pacientes reumatológicos apresentaram suscetibilidade semelhante à infecção/hospitalização da população geral. A idade avançada e a presença de comorbidades são fatores associados ao risco aumentado de infecção grave e hospitalização por Covid-19. Quanto à terapia imunossupressora, pacientes em uso de Rituximabe ou de glicocorticosteróides de forma crônica, apresentam maior taxa de hospitalização e infecção grave por Covid-19, com aquele aumentando ainda o risco de morte. Já o uso de anti-TNF alfa apresentam efeito protetor.